The Efficacy and Duration of Onabotulinum Toxin A in Improving Upper Facial Expression Lines With 64-Unit Dose Optimization: A Systematic Review and Meta-Analysis With Trial Sequential Analysis of the Randomized Controlled Trials
- 13 September 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 43 (2) , 215-229
Abstract
Background: Onabotulinumtoxin A (Onabot A) was the first treatment to be approved for aesthetic indications, namely glabellar lines (GLs), crow's feet lines (CFLs), and forehead lines (FHLs), with a cumulative dose of 64 U.Objectives: The aim of this study was to conduct a meta-analysis to combine the available data for approved doses for GLs, CFLs, and FHLs to explore the effect and duration of simultaneous treatment with Onabot A.Methods: PubMed/MEDLINE, Embase, and other national clinical trial registries were searched for randomized controlled trials from January 2010 to July 2022. The meta-analysis, trial sequential analysis, and investigator-assessed time to return to nonresponder status in GLs, CFLs, and FHLs following Onabot A were plotted to elicit a cumulative dose-adjusted response curve based on Kaplan-Meier analysis with a log-rank test.Results: Fourteen randomized controlled trials were eligible for quantitative analysis. A total of 8369 subjects were recruited across the trials. The meta-analysis results show that Onabot A is very effective in reducing moderate to severe GLs, CFLs, and FHLs. The cumulative Z-curve for GLs, CFLs, and FHLs also exceeds the required information size (RIS). Kaplan-Meier analysis with a log-rank test demonstrated that simultaneous treatment of GLs, CFLs, and FHLs requires 182 days (95% CI = 179, 215 days) (P < 0.00002) to return to nonresponder status.Conclusions: Treatment of the upper facial expression lines with Onabot A is effective, and the approved cumulative dose of 64 U gives longer-lasting effects.Level of Evidence: 1:Keywords
This publication has 98 references indexed in Scilit:
- Self-monitoring of social facial expressions in the primate amygdala and cingulate cortexProceedings of the National Academy of Sciences, 2012
- Inter-rater and test–retest reliability of quality assessments by novice student raters using the Jadad and Newcastle–Ottawa ScalesBMJ Open, 2012
- Evidence at a glance: error matrix approach for overviewing available evidenceBMC Medical Research Methodology, 2010
- Forest plots in reports of systematic reviews: a cross-sectional study reviewing current practiceInternational Journal of Epidemiology, 2010
- A Double-Blind, Randomized, Placebo-Controlled, Two-Dose Comparative Study of Botulinum Toxin Type A for Treating Glabellar Lines in Japanese SubjectsAesthetic Plastic Surgery, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960